US Stock MarketDetailed Quotes

TBPH Theravance Biopharma

Watchlist
  • 9.725
  • +0.015+0.15%
Trading Dec 19 13:11 ET
478.22MMarket Cap-9.44P/E (TTM)

Theravance Biopharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Theravance Biopharma Q3 2024 Earnings Date

Currency：USDNov 12, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
15.42M
16.87M
+1.44M
Beat Est.
-1.72%
+7.49%
+9.36%
EPS
-0.23
-0.26
-0.03
Miss Est.
-35.31%
-52.94%
-13.09%
Analyst Rating
Buy

Nov 30, 2024

Theravance Biopharma Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 16.100M--
--2024/Q4-- / 27.316M--
Nov 12, 20242024/Q316.868M / 15.424M--
Aug 5, 20242024/Q214.256M / 15.307M--
May 13, 20242024/Q114.503M / 13.950M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 16.100M--
--2024/Q4-- / 27.316M--
Nov 12, 20242024/Q316.868M / 15.424M--
Aug 5, 20242024/Q214.256M / 15.307M--
May 13, 20242024/Q114.503M / 13.950M--

Unlock Free Earnings Estimates

Theravance Biopharma Earnings Reports

  • Theravance Biopharma | 10-Q: Q3 2024 Earnings Report

    Nov 14 06:11 ET

  • Theravance Biopharma | 8-K: Theravance Biopharma, Inc. Reports Third Quarter 2024 Financial Results and Announces Initiatives to Unlock Shareholder Value

    Nov 12 16:14 ET

  • Theravance Biopharma | 10-Q: Q2 2024 Earnings Report

    Aug 8 17:00 ET

  • Theravance Biopharma | 8-K: Theravance Biopharma, Inc. Reports Second Quarter 2024 Financial Results and Provides Business Update

    Aug 5 16:18 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Nov 30, 2024

    Buy

    • Buy

      25.00%

    • Hold

      75.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Price
    % Chg

    No Data